Press release
GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development
Leading chemistry services organisation, Onyx Scientific Ltd, is pleased to announce an increased demand for its early-phase, GMP synthesis, Investigational New Drug (IND) services for the development of Active Pharmaceutical Ingredients (APIs).“At Onyx we plan for success by focussing on detail” explains CEO Tony Flinn. “Our service driven systems deliver comprehensive chemical route development, efficient raw materials sourcing, thorough analysis and world-class solid-state characterization. We are recognised as the leading GMP synthesis provider and are increasingly viewed as THE company to support the development of value for money INDs”.
Dr Daryl Rees, Chief Executive, Salupont Consulting comments, "Having worked with Onyx Scientific for many years, I can say they are one of the finest suppliers in the marketplace. They have delivered a range of different services both on time and on budget, without hidden costs. Their GMP offering has been of particular use to us and we continually find that Onyx delivers excellent value for money".
An equally valued client adds, “I don't think there’s another team I’ve worked with who respond so quickly and flexibly to the regulators, and to my many questions. All data generated is of the highest quality. My many calls are met with good humour, practicality, pragmatism and a lot of patience. It's genuinely rare to work with a partner who demonstrates such a high degree of commitment. Reagents were ordered ahead of me asking, Onyx worked late, missed holiday leave and ran experiments over the weekend. The service they provide is above and beyond anything I'd have expected and it has made my job here so much easier”.
Good manufacturing practice (GMP) compliance is an international requirement for the manufacture of medicinal products for human and veterinary use. Compliance ensures medicinal products are produced safely and correctly. GMP Synthesis is the term commonly associated with manufacturing for Clinical Phases 1 to 3.
In addition to GMP synthesis and scale up, Onyx Scientific’s breath of services include solid-form polymorph screening, salt selection, custom synthesis, process development and lead optimization. Visit: http://www.onyx-scientific.com
Leading global GMP chemistry services organisation
Onyx Scientific Limited
Silverbriar
Enterprise Park East
Sunderland
SR5 2TQ
United Kingdom
Tel: +44 (0) 191 516 6516
http://www.onyx-scientific.com
suejones@onyx-scientific.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GMP Synthesis chemistry services organisation, Onyx Scientific, announce increased demand for early-phase Investigational New Drug (IND) development here
News-ID: 167864 • Views: …
More Releases from Onyx Scientific Ltd

Custom Synthesis chemistry services CRO, Onyx Scientific, hails the success of i …
Onyx Scientific, a trusted global chemistry services CRO and leading provider of high justified intermediates and APIs for both phase I and phase II clinical studies, hails the success of its world-class solid-state polymorph screening services for the increased demand for its international GMP-compliant Process Development capability.
Onyx Scientific specialise in Medicinal Chemistry, Process Development, Custom Synthesis, GMP synthesis and Scale-up, in addition to a comprehensive range of Analytical and…

Solid-state chemistry services CRO, Onyx Scientific reports increased demand for …
Experts in the provision of solid-state chemistry services for the pharmaceutical and biotech industries, leading global contract research organisation, Onyx Scientific, is delighted to report increased demand in taking candidate compounds from concept through to process development and scale-up of APIs for Phase I and Phase II clinical studies.
“Handling difficult-to-crystallize materials is an art form as well as a science” explains Tony Flinn, CEO, Onyx Scientific. “Inherently complicated, the implications…

GMP synthesis chemistry services CRO, Onyx Scientific, reports increased small s …
Internationally renowned, contract research organisation Onyx Scientific, is pleased to announce the continued growth of its small-scale GMP custom synthesis services for development APIs (Active Pharmaceutical Ingredients)
Commenting on the growing success of its small-scale GMP synthesis services, CEO, Dr Tony Flinn says “our success is due to open communication and a highly responsive scientific team, who are able to lower the cost of a GMP process by…

Polymorph screening chemistry services CRO, Onyx Scientific, announces the conti …
Polymorph screening specialists, Onyx Scientific Ltd – chemistry outsourcing partner to the pharma and biotech industries – today announced the record-breaking growth of its solid-state chemistry services for the discovery, analysis and scale-up of polymorphs, hydrates, amorphous phases, salts and co-crystals of Active Pharmaceutical Ingredients (APIs).
In close partnership with an international client base and often working with just a few grams of precious API material, Onyx Scientific performs highly specific…
More Releases for GMP
Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides.
As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more…
Diapharm implements European GMP guidelines in China
Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm (diapharm.com) is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd (www.neptunepharma.com) in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (www.trident-50.com), is manufactured onsite under EU…
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service – the new GMP WebApp.
This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows users…
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials
AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008.
“ISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,” said Jerry Lynch,…
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG – GMP Publish …
GMP Publishing is launching its new GMP MANUAL Volume 2 – Validation Procedures.
The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat – all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive style…
blue inspection body celebrates 50 GMP audits
Münster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,…